TUCSON, Ariz., November 7, 2024 — Critical Path Institute® (C-Path) today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine ...
Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled “Transforming Drug Development for Neurological Disorders: Proceedings from a ...
The Tucson-based Critical Path Institute has no laboratories, no drug chemists, no patent lawyers. Yet the nonprofit is arguably one of the most important emerging drug-research organizations in the ...
Critical Path Institute (C-Path) announced today that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) from the U.S. Food and Drug Administration (FDA) ...
Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) announced today a new research grant awarded to Daniela C. Zarnescu, Ph.D., Professor of Cellular and Molecular ...
The Tucson-based Critical Path Institute has been awarded a $9 million investment grant from Science Foundation Arizona to boost the institute's mission of improving the drug development process.
The MarketWatch News Department was not involved in the creation of this content. Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 ...
TUCSON, Ariz., Sept. 27, 2022 /PRNewswire/ -- Critical Path Institute (C-Path) today named Daniel M. Jorgensen, M.D., MPH, MBA, its Chief Executive Officer (CEO). An experienced leader in drug ...
Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership (PPP) to benefit people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback